147 related articles for article (PubMed ID: 15964416)
1. Transforming growth factor beta1-modified donor cell transfusion induced allo-heart tolerance.
Cheng J; Xia SS; Xie S; Tang LG; Shi XF
Transplant Proc; 2005 Jun; 37(5):2360-4. PubMed ID: 15964416
[TBL] [Abstract][Full Text] [Related]
2. Immunotolerance reaction for allograft-limb in rats induced by gene-modified cell transfusion.
Li W; Yue WJ; Yue Q; Yang DW; Meng QG
Panminerva Med; 2010 Dec; 52(4):289-95. PubMed ID: 21183889
[TBL] [Abstract][Full Text] [Related]
3. A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance.
Josien R; Douillard P; Guillot C; Müschen M; Anegon I; Chetritt J; Menoret S; Vignes C; Soulillou JP; Cuturi MC
J Clin Invest; 1998 Dec; 102(11):1920-6. PubMed ID: 9835616
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta(1) gene modified immature dendritic cells exhibit enhanced tolerogenicity but induce allograft fibrosis in vivo.
Sun W; Wang Q; Zhang L; Pan J; Zhang M; Lu G; Yao H; Wang J; Cao X
J Mol Med (Berl); 2002 Aug; 80(8):514-23. PubMed ID: 12185452
[TBL] [Abstract][Full Text] [Related]
5. Opposite effects of donor apoptotic versus necrotic splenocytes on splenic allograft tolerance.
Jiang H; Lu Z; Pan S; Sun B; Meng F; Tan H; Meng Q; Sun X
J Surg Res; 2006 Dec; 136(2):247-54. PubMed ID: 17056068
[TBL] [Abstract][Full Text] [Related]
6. [Effects of TGF-beta1, gene modified donor dendritic cells on immune repulsion].
Liu N; Duan TD; Zheng N
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 37(5):721-5. PubMed ID: 17037736
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis and the expression of genes of the Bcl-2 family and TGF-beta1 in rat renal allografts transplanted after donor-specific blood transfusion.
Jablonski P; Goh BL; Maguire J; Glogowski I; Howden BO; Thomson NM; Stein AN
Transplant Proc; 2005; 37(1):93-5. PubMed ID: 15808558
[TBL] [Abstract][Full Text] [Related]
8. Retroviral delivery of transforming growth factor-beta1 to myeloid dendritic cells: inhibition of T-cell priming ability and influence on allograft survival.
Takayama T; Kaneko K; Morelli AE; Li W; Tahara H; Thomson AW
Transplantation; 2002 Jul; 74(1):112-9. PubMed ID: 12134108
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta/interleukin-2-induced regulatory CD4+ T cells prolong cardiac allograft survival in rats.
Watanabe M; Mencel RL; Cramer DV; Starnes VA; Barr ML
J Heart Lung Transplant; 2005 Dec; 24(12):2153-9. PubMed ID: 16364865
[TBL] [Abstract][Full Text] [Related]
10. Anti-transforming growth factor antibody at low but not high doses limits cyclosporine-mediated nephrotoxicity without altering rat cardiac allograft survival: potential of therapeutic applications.
Khanna AK; Plummer MS; Hilton G; Pieper GM; Ledbetter S
Circulation; 2004 Dec; 110(25):3822-9. PubMed ID: 15583082
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of transforming growth factor-beta and eosinophil infiltration is associated with the development of transplant arteriosclerosis in long-term surviving cardiac allografts.
Spriewald BM; Ensminger SM; Billing JS; Morris PJ; Wood KJ
Transplantation; 2003 Oct; 76(7):1105-11. PubMed ID: 14557761
[TBL] [Abstract][Full Text] [Related]
12. [Induced tolerance to cardiac allografts with multiple intravenous injection of donor spleen cells].
Guo HW; Wu QY; Xie SS; Zhang QY; Yang XB; Shao MP
Zhonghua Wai Ke Za Zhi; 2004 Jun; 42(11):664-7. PubMed ID: 15329255
[TBL] [Abstract][Full Text] [Related]
13. Improvement of heart allograft acceptability associated with recruitment of CD4+CD25+ T cells in peripheral blood by recipient treatment with granulocyte colony-stimulating factor.
Liang HL; Yi DH; Zheng QJ; Du JF; Cao YX; Yu SQ; Zhu HL
Transplant Proc; 2008 Jun; 40(5):1604-11. PubMed ID: 18589159
[TBL] [Abstract][Full Text] [Related]
14. Influence of mast cells on outcome after heterotopic cardiac transplantation in rats.
Boerma M; Fiser WP; Hoyt G; Berry GJ; Joseph L; Joseph J; Wang J; Crew MD; Robbins RC; Hauer-Jensen M
Transpl Int; 2007 Mar; 20(3):256-65. PubMed ID: 17291219
[TBL] [Abstract][Full Text] [Related]
15. Serum suppressive factor appears to potentiate cardiac allograft survival after portal vein injection of ultraviolet B-irradiated donor spleen cells.
Yu S; Nakafusa Y; Flye MW
Transplant Proc; 1993 Feb; 25(1 Pt 1):500-1. PubMed ID: 8438394
[No Abstract] [Full Text] [Related]
16. Effect of streptavidin on cardiac allograft prolongation is due to host T-Cell suppression.
Witkowski P; Fawwaz RA; Jin MX; DePaz HA; Oluwole OO; Hardy MA; Oluwole SF
Transplant Proc; 2005; 37(1):116-8. PubMed ID: 15808566
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of transforming growth factor-beta1 stabilizes already-formed aortic aneurysms: a first approach to induction of functional healing by endovascular gene therapy.
Dai J; Losy F; Guinault AM; Pages C; Anegon I; Desgranges P; Becquemin JP; Allaire E
Circulation; 2005 Aug; 112(7):1008-15. PubMed ID: 16103255
[TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone suppresses cyclosporin-induced chronic transplant dysfunction and prolongs survival of rat cardiac allografts.
Chen Y; Liu Y; Yuan Z; Tian L; Dallman MJ; Thompson PW; Tam PK; Lamb JR
Transplantation; 2007 Jun; 83(12):1602-10. PubMed ID: 17589344
[TBL] [Abstract][Full Text] [Related]
19. Cotransfection with IL-10 and TGF-β1 into immature dendritic cells enhances immune tolerance in a rat liver transplantation model.
Chen L; Zheng L; He W; Qiu M; Gao L; Liu J; Huang A
Am J Physiol Gastrointest Liver Physiol; 2014 Apr; 306(7):G575-81. PubMed ID: 24503768
[TBL] [Abstract][Full Text] [Related]
20. Intrasplenic transplantation of allogeneic hepatocytes prolongs survival in anhepatic rats.
Arkadopoulos N; Lilja H; Suh KS; Demetriou AA; Rozga J
Hepatology; 1998 Nov; 28(5):1365-70. PubMed ID: 9794923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
